LON:SHP Shire (SHP) Share Price, News & Analysis → Like Tiny Crypto Retirement Funds (From Crypto 101 Media) (Ad) Free SHP Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume51,588 shsAverage Volume3.14 million shsMarket Capitalization£42.73 billionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Shire alerts: Email Address Ad Banyan Hill PublishingAI Cracks Open Largest Untapped Energy Reserve on EarthThis orb represents the largest untapped energy source in the world… And although this energy resource is unknown by 99% of the public… It makes gas, coal, oil, wind, hydropower, solar, fusion… ]click here to watch a free presentation where I reveal all the details of this lucrative opportunit About Shire Stock (LON:SHP)Shire plc, a biotechnology company, researches, develops, licenses, manufactures, markets, distributes, and sells medicines for rare diseases and other specialized conditions worldwide. The company offers products in therapeutic areas, including hematology, genetic diseases, neuroscience, immunology, internal medicine, ophthalmology, and oncology. Its marketed products include ADVATE, ADYNOVATE/ADYNOVI, and OBIZUR for the treatment of hemophilia A; RIXUBIS to treat hemophilia B; VONVENDI for the treatment of von willebrand disease; FEIBA to treat hemophilia A and B patients with inhibitors; ELAPRASE to treat hunter syndrome; REPLAGAL for fabry disease; and VPRIV to treat type 1 Gaucher disease. The company's marketed products also comprise VYVANSE/VENVANSE/ELVANSE/TYVENSE/VUXEN/ADUVANZ for the treatment of attention deficit/hyperactivity disorder (ADHD) and binge eating disorder; ADDERALL XR and MYDAYIS to treat ADHD; GAMMAGARD LIQUID/KIOVIG, GAMMAGARD S/D, HYQVIA, and CUVITRU for the treatment of primary immunodeficiency; and FLEXBUMIN to treat hypovolemia and hypoalbuminemia. In addition, its marketed products consists of CINRYZE and FIRAZYR for the treatment of hereditary angioedema; FOSRENOL to treat hyperphosphatemia; LIALDA/MEZAVANT and PENTASA for ulcerative colitis; GATTEX/REVESTIVE for the treatment of short bowel syndrome; NATPARA for the control of hypocalcemia in patients with hypoparathyroidism; ONCASPAR to treat acute lymphoblastic leukemia; ONYVIDE for metastatic adenocarcinoma of the pancreas; and XIIDRA for the treatment of dry eye disease. The company markets its products through wholesalers, distributors, and pharmacies. It has collaborative and other licensing arrangements with Rani Therapeutics LLC; Parion Sciences Inc.; Pfizer Inc.; Precision BioSciences Inc.; Symphogen; and Ipsen Bioscience Inc., as well as a preclinical research collaboration agreement with NanoMedSyn. The company was founded in 1986 and is headquartered in Dublin, Ireland.Read More Ad Prosper Trading AcademyDid you make $29,000 two days with AI options trades?What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:Click Here To Get Your Free Copy SHP Stock News HeadlinesOctober 20, 2022 | bbc.comWhy the capture of Shire is so important for Ethiopia - BBCOctober 17, 2022 | reuters.comEthiopian army captures large city from Tigray forces: sources - ReutersMarch 19, 2024 | Colonial Metals (Ad)Central Bank Gold Heist In ProgressWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.October 16, 2022 | barrons.comAU Calls On Ethiopia Rivals To 'Recommit' To Peace - Barron'sOctober 12, 2022 | news.yahoo.comShire Chic? This $30 Million Mountaintop Lodge in North Carolina Comes With a Hobbit-Style Guest House - Yahoo NewsOctober 11, 2022 | nypost.comLoose lips lead to lawsuits over allegations from 'The Godfather' set - New York Post October 11, 2022 | yahoo.comShire Chic? This $30 Million Mountaintop Lodge in North Carolina Comes With a Hobbit-Style Guest House - Yahoo LifeOctober 9, 2022 | uk.news.yahoo.comDeputy Mayor and Thwaites Horse Shire team open new kitchen facility - Yahoo News UKMarch 19, 2024 | Porter & Company (Ad)The world’s greatest investmentI believe this could change your life forever. I’m talking about transforming everything for you, financially. You see, a rare market anomaly has emerged that I believe is going to make some people very wealthy. Almost nobody in the mainstream media or Wall Street has connected the dots on what’s going on, but that ignorance won’t last for long. When they wake up to this situation, billions of dollars will flood in.October 7, 2022 | forbes.comKansas City Chiefs Linemen Creed Humphrey And Trey Smith Use T-Shirts To Build Brand - ForbesOctober 7, 2022 | cnn.comKanye West tells Tucker Carlson he thought 'White Lives Matter' shirt was 'funny' - CNNOctober 1, 2022 | mirror.co.ukThe Queen's 'special' grey shire horses pay their respects with final act of service - The MirrorSeptember 30, 2022 | dailymail.co.ukJANE FRYER: Queen's 'special' grey shire horses 'pay their respects' to the late monarch - Daily MailSeptember 30, 2022 | startribune.comWitnesses: Airstrike in Ethiopia's Tigray kills civilians - Star TribuneSeptember 30, 2022 | abcnews.go.comWitnesses: Airstrike in Ethiopia's Tigray kills civilians - ABC NewsSeptember 27, 2022 | forbes.com2023 Bentley Bentayga EWB First Drive: A Thoroughbred Among Shire Horses - ForbesSeptember 26, 2022 | uk.news.yahoo.comTwo Shire horses take Queen’s flowers away for composting - Yahoo News UKSeptember 7, 2022 | npr.orgSinger-songwriter Amanda Shires reflects on marriage on 'Take it Like a Man' - NPRSeptember 5, 2022 | npr.orgPeeling back the layers of Amanda Shires' life and musical career : World Cafe Words and Music Podcast - NPRAugust 7, 2022 | bbc.comCouncil makes money-saving move closer to city centre - BBCAugust 3, 2022 | news.yahoo.com'I'm gonna do me': Amanda Shires on women in country music and her new album 'Take It Like a Man' - Yahoo NewsJuly 31, 2022 | npr.orgAmanda Shires talks new album 'Take It Like A Man' - NPRJuly 31, 2022 | theguardian.comFrom WAG Nation to The Shire: the 15 Australian reality shows we all forgot about – sorted - The GuardianJuly 18, 2022 | bbc.comStafford business centre opens in town's historic Shire Hall - BBCJuly 9, 2022 | bbc.comCambridgeshire council officially opens Alconbury HQ - BBCJuly 7, 2022 | dailymail.co.ukBass Coast Shire Council announces cat ban and fines to protect Phillip Island penguins - Daily MailJune 17, 2022 | dailymail.co.ukMad Max prequel Furiosa to be filmed near Sydney's Sutherland Shire - Daily MailSee More Headlines Receive SHP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Shire and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:SHP CUSIPN/A CIKN/A Webwww.shire.com Phone+353-1-6096000FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares910,982,976Free FloatN/AMarket Cap£42.73 billion OptionableNot Optionable BetaN/A 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesDr. Flemming Ornskov M.P.H. (Age 60)MBA, M.D., MPH, CEO, MD & Exec. Director Mr. Thomas J. W. Dittrich (Age 54)CFO & Director Gisele DionChief Accounting OfficerMr. Matthew Walker (Age 54)Head of Technical Operations Dr. Andreas Busch Ph.D. (Age 55)Head of R&D and Chief Scientific Officer Key CompetitorsHaleonLON:HLNGSKLON:GSKAstraZenecaLON:AZNBTGLON:BTGAbcamLON:ABCView All Competitors Should I Buy Shire Stock? SHP Pros and Cons Explained These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Shire was last updated on Monday, March 18, 2024 at 12:06 AM. Pros Here are some ways that investors could benefit from investing in Shire plc: Shire plc offers a diverse range of products in therapeutic areas such as hematology, genetic diseases, neuroscience, and oncology, providing a broad revenue base. The company has a strong focus on researching, developing, and selling medicines for rare diseases and specialized conditions, tapping into niche markets with potentially high demand. Recent collaborations and licensing agreements with reputable companies like Pfizer Inc. and Precision BioSciences Inc. indicate potential for future growth and innovation in product development. Shire plc's presence in multiple international markets allows for geographic diversification, reducing risks associated with regional economic fluctuations. Investors may find the current stock price of Shire plc attractive, potentially offering a favorable entry point for investment. Cons Investors should be bearish about investing in Shire plc for these reasons: Shire plc operates in the biotechnology industry, which can be highly competitive and subject to regulatory challenges, leading to uncertainties in product approvals and market acceptance. The company's focus on rare diseases and specialized conditions may limit the overall market size compared to companies with broader product portfolios, potentially impacting revenue growth. Fluctuations in foreign exchange rates could affect Shire plc's financial performance, especially considering its global operations and revenue streams. Market volatility and macroeconomic factors could influence investor sentiment towards biotechnology companies like Shire plc, leading to potential stock price fluctuations. Investors should carefully consider the risks associated with investing in a company that heavily relies on research and development for product innovation, as failures in clinical trials or regulatory setbacks could impact financial performance. SHP Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Shire own? Based on aggregate information from My MarketBeat watchlists, some companies that other Shire investors own include Barclays (BARC), Centrica (CNA), Erie Indemnity (ERIE), Lloyds Banking Group (LLOY), GSK (GSK), International Consolidated Airlines Group (IAG), Vodafone Group Public (VOD), Prudential (PRU), Shire (SHPG) and Randgold Resources (RRS). This page (LON:SHP) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial MetalsLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThe world’s greatest investmentPorter & CompanySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shire plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.